Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line.
Nazila Fathi MaroufiMohsen RashidiVahid VahedianRaheleh JahanbaziSahar MostafaeiMaryam AkbarzadehHamid KazemzadehHamid-Reza NejabatiAlireza IsazadehMohammad Reza RashidiMohammad NouriPublished in: Breast cancer (Tokyo, Japan) (2021)
Apatinib or a combination of Apatinib/melatonin may be used to manage patients with breast cancer. However, further studies are needed to identify anti-cancer mechanisms of melatonin and Apatinib for better management of the patients with breast cancer.